https://www.selleckchem.com/pr....oducts/gsk2578215a.h
0001), and results were maintained through 3 cycles of onabotulinumtoxinA. Conclusions OnabotulinumtoxinA treatment also resulted in high patient satisfaction rates. The incidence of eyebrow and of eyelid ptosis was low, and no new safety signals were detected. OnabotulinumtoxinA is safe and effective and an appropriate option for patients with moderate to severe FHL encountered in clinical practice.Immediate fat grafting to the pedicled myocutaneous latissimus dorsi (LD) flap has recently gained in popularity as a means to suppleme
Like
Comment
Share
